pioglitazone has been researched along with isohumulone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ezaki, O; Fujiwara, D; Ikeshima, E; Kanaya, T; Kondo, K; Odai, H; Oikawa, S; Shiraki, M; Tsuboyama-Kasaoka, N; Yajima, H | 1 |
1 trial(s) available for pioglitazone and isohumulone
Article | Year |
---|---|
Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance.
Topics: Aged; Animals; Blood Glucose; Body Weight; Cyclopentanes; Diabetes Mellitus, Type 2; Dietary Fats; DNA-Binding Proteins; Double-Blind Method; Fatty Acids, Nonesterified; Female; Glycated Hemoglobin; Humans; Humulus; Insulin Resistance; Lipoprotein Lipase; Male; Mice; Mice, Inbred C57BL; Middle Aged; Pilot Projects; Pioglitazone; Placebos; Plant Extracts; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; RNA, Messenger; Saccharomyces cerevisiae Proteins; Thiazolidinediones; Transcription Factors; Transfection; Triglycerides; Weight Gain | 2004 |